Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype
- PMID: 14583457
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype
Abstract
A database has been created to collect information on families carrying a germ-line mutation in the TP53 gene and on families affected with Li-Fraumeni syndromes [Li-Fraumeni syndrome (LFS) and Li-Fraumeni-like syndrome (LFL)]. Data from the published literature have been included. The database is available online at http://www.iarc.fr/p53, as part of the IARC TP53 Database. The analysis of the 265 families/individuals that have been included thus far has revealed several new findings. In classical LFS families with a germ-line TP53 mutation (83 families), the mean age of onset of breast cancer was significantly lower than in LFS families (16 families) without a TP53 mutation (34.6 versus 42.5 years; P = 0.0035). In individuals with a TP53 mutation, a correlation between the genotype and phenotype was found. Brain tumors were associated with missense TP53 mutations located in the DNA-binding loop that contact the minor groove of DNA (P = 0.01), whereas adrenal gland carcinomas were associated with missense mutations located in the loops opposing the protein-DNA contact surface (P = 0.003). Finally, mutations likely to result in a null phenotype (absence of the protein or loss of function) were associated with earlier onset brain tumors (P = 0.004). These observations have clinical implications for genetic testing and tumor surveillance in LFS/LFL families.
Similar articles
-
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.J Med Genet. 2010 Jun;47(6):421-8. doi: 10.1136/jmg.2009.073429. J Med Genet. 2010. PMID: 20522432
-
Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.Oncogene. 1998 Sep 3;17(9):1061-8. doi: 10.1038/sj.onc.1202033. Oncogene. 1998. PMID: 9764816
-
Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.Cancer Res. 1997 Aug 1;57(15):3245-52. Cancer Res. 1997. PMID: 9242456
-
Germline TP53 mutations and Li-Fraumeni syndrome.Hum Mutat. 2003 Mar;21(3):313-20. doi: 10.1002/humu.10185. Hum Mutat. 2003. PMID: 12619118 Review.
-
[Li-Fraumeni syndrome].Bull Cancer. 1997 Jul;84(7):735-40. Bull Cancer. 1997. PMID: 9339200 Review. French.
Cited by
-
Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing.Cancer Biol Med. 2016 Mar;13(1):55-67. doi: 10.28092/j.issn.2095-3941.2016.0002. Cancer Biol Med. 2016. PMID: 27144062 Free PMC article.
-
[Li-Fraumeni syndrome].Radiologie (Heidelb). 2022 Dec;62(12):1026-1032. doi: 10.1007/s00117-022-01071-x. Epub 2022 Sep 27. Radiologie (Heidelb). 2022. PMID: 36166074 Review. German.
-
Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.Mol Diagn Ther. 2013 Feb;17(1):31-47. doi: 10.1007/s40291-013-0020-0. Mol Diagn Ther. 2013. PMID: 23355100 Free PMC article. Review.
-
Increased oxidative damage in carriers of the germline TP53 p.R337H mutation.PLoS One. 2012;7(10):e47010. doi: 10.1371/journal.pone.0047010. Epub 2012 Oct 9. PLoS One. 2012. PMID: 23056559 Free PMC article.
-
Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumor.Fam Cancer. 2011 Mar;10(1):141-6. doi: 10.1007/s10689-010-9392-z. Fam Cancer. 2011. PMID: 20967502 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous